A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway.
Through cell-based screening models, we have identified a new compound IMB5043, a thiophenylated pyridazinone, which exerted cytotoxicity against cancer cells. In the present study, we evaluated its antitumor efficacy and the possible mechanism. By MTT assay, IMB5043 inhibited the proliferation of v...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5796703?pdf=render |
id |
doaj-36710e6d2df94d3198bc0047d29d345d |
---|---|
record_format |
Article |
spelling |
doaj-36710e6d2df94d3198bc0047d29d345d2020-11-24T20:40:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01132e019198410.1371/journal.pone.0191984A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway.Jianhua GongYanbo ZhengYing WangWeijin ShengYi LiXiujun LiuShuyi SiRongguang ShaoYongsu ZhenThrough cell-based screening models, we have identified a new compound IMB5043, a thiophenylated pyridazinone, which exerted cytotoxicity against cancer cells. In the present study, we evaluated its antitumor efficacy and the possible mechanism. By MTT assay, IMB5043 inhibited the proliferation of various human cancer cells lines, especially hepatocarcinoma SMMC-7721 cells. IMB5043 blocked cell cycle with G2/M arrest, induced cell apoptosis, and inhibited the migration and invasion of SMMC-7721 cells. As verified by comet assay and γ-H2AX foci formation, IMB5043 caused DNA damage and activated ATM, Chk2 and p53 through phosphorylation. As shown by Gene microarray analysis, the differentially expressed genes in SMMC-7721 cells treated with IMB5043 were highly related to cell death and apoptosis. IMB5043 suppressed the growth of hepatocarcinoma SMMC-7721 xenograft in athymic mice. By histopathological examination, no lesions were found in bone marrow and various organs of the treated mice. Our findings reveal that IMB5043 as an active compound consisting of both pyridazinone and thiophene moieties exerts antitumor efficacy through activation of ATM-Chk2 pathway. IMB5043 may serve as a promising leading compound for the development of antitumor drugs.http://europepmc.org/articles/PMC5796703?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jianhua Gong Yanbo Zheng Ying Wang Weijin Sheng Yi Li Xiujun Liu Shuyi Si Rongguang Shao Yongsu Zhen |
spellingShingle |
Jianhua Gong Yanbo Zheng Ying Wang Weijin Sheng Yi Li Xiujun Liu Shuyi Si Rongguang Shao Yongsu Zhen A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway. PLoS ONE |
author_facet |
Jianhua Gong Yanbo Zheng Ying Wang Weijin Sheng Yi Li Xiujun Liu Shuyi Si Rongguang Shao Yongsu Zhen |
author_sort |
Jianhua Gong |
title |
A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway. |
title_short |
A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway. |
title_full |
A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway. |
title_fullStr |
A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway. |
title_full_unstemmed |
A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway. |
title_sort |
new compound of thiophenylated pyridazinone imb5043 showing potent antitumor efficacy through atm-chk2 pathway. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2018-01-01 |
description |
Through cell-based screening models, we have identified a new compound IMB5043, a thiophenylated pyridazinone, which exerted cytotoxicity against cancer cells. In the present study, we evaluated its antitumor efficacy and the possible mechanism. By MTT assay, IMB5043 inhibited the proliferation of various human cancer cells lines, especially hepatocarcinoma SMMC-7721 cells. IMB5043 blocked cell cycle with G2/M arrest, induced cell apoptosis, and inhibited the migration and invasion of SMMC-7721 cells. As verified by comet assay and γ-H2AX foci formation, IMB5043 caused DNA damage and activated ATM, Chk2 and p53 through phosphorylation. As shown by Gene microarray analysis, the differentially expressed genes in SMMC-7721 cells treated with IMB5043 were highly related to cell death and apoptosis. IMB5043 suppressed the growth of hepatocarcinoma SMMC-7721 xenograft in athymic mice. By histopathological examination, no lesions were found in bone marrow and various organs of the treated mice. Our findings reveal that IMB5043 as an active compound consisting of both pyridazinone and thiophene moieties exerts antitumor efficacy through activation of ATM-Chk2 pathway. IMB5043 may serve as a promising leading compound for the development of antitumor drugs. |
url |
http://europepmc.org/articles/PMC5796703?pdf=render |
work_keys_str_mv |
AT jianhuagong anewcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT yanbozheng anewcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT yingwang anewcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT weijinsheng anewcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT yili anewcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT xiujunliu anewcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT shuyisi anewcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT rongguangshao anewcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT yongsuzhen anewcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT jianhuagong newcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT yanbozheng newcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT yingwang newcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT weijinsheng newcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT yili newcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT xiujunliu newcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT shuyisi newcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT rongguangshao newcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway AT yongsuzhen newcompoundofthiophenylatedpyridazinoneimb5043showingpotentantitumorefficacythroughatmchk2pathway |
_version_ |
1716827423975145472 |